(Q40679509)

22 September 2017

1 reference

title

The role of Rh antibodies in haemolytic disease of the newborn (English)

1 reference

22 September 2017

Hadley AG

1

1 reference

22 September 2017

Kumpel BM

series ordinal

2

1 reference

22 September 2017

language of work or name

1 reference

1 June 1993

1 reference

Best Practice and Research: Clinical Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

6

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

423-444

1 reference

Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Blood group-active surface molecules of the human red blood cell

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Phagocytosis by human monocytes in red cells coated with Rh antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red-cell membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The prevention of Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Reversal of Rh alloimmunization. Fact or fancy?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rhesus haemolytic disease of the newborn and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Further Experimental Studies on the Prevention of Rh Haemolytic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rhesus Du incompatibility in a newborn with high levels of anti D and a benign clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The immune destruction of red cells*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Experimental studies on the prevention of Rh haemolytic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Intensive antenatal plasmapheresis in severe rhesus isoimmunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Successful Prevention of Experimental Rh Sensitization in Man with an Anti‐Rh Gamma2‐Globulin Antibody Preparation: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rh isoimmunization: a 24 year experience at Duke University Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The Importance of Monitoring ‘Enzyme-Only’ Red Cell Antibodies during Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Mononuclear phagocyte assays, autoanalyzer quantitation and IgG subclasses of maternal anti-RhD in the prediction of the severity of haemolytic disease in the fetus before 32 weeks gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Plasmapheresis in Rh hemolytic disease: the danger of amniocentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Management of serious alloimmunization in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The solution conformations of the subclasses of human IgG deduced from sedimentation and small angle X-ray scattering studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

An in-vitro assessment of the functional activity of monoclonal anti-D

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Predicting the severity of haemolytic disease of the newborn: prospective evaluation of the chemiluminescence test

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The immune complex: possible ways of regulating the antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Human monoclonal antibodies and haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Deaths from haemolytic disease of the newborn in 1990

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Management of severe hemolytic disease with ultrasound-guided intravascular fetal transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

A simple non-isotopic method for the quantitation of red cell-bound immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Human monoclonal anti-D antibodies. I. Their production, serology, quantitation and potential use as blood grouping reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

AN UNUSUAL CASE OF INTRA-GROUP AGGLUTINATION

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The role of iso-immunization in the pathogenesis of erythroblastosis fetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Deaths from haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

High-dose intravenous IgG for the treatment of severe rhesus alloimmunization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The significance of anti-Kell sensitization in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rh immunization by the partial D antigen of category DVa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Detection of fetal erythrocytes in maternal blood post partum with the fluorescence-activated cell sorter

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Requirements for the establishment of heterohybridomas secreting monoclonal human antibody to rhesus (D) blood group antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

A quantitative antiglobulin test for IgG for use in blood transfusion serology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

RATE OF REMOVAL FROM THE CIRCULATION OF RED CELLS SENSITIZED WITH DIFFERENT AMOUNTS OF ANTIBODY

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Human IgG subclasses in maternal and fetal serum

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The effect of Rh genotypes on severity in haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rhesus-Du and -D incompatibility in the newborn without haemolytic disease: inhibition of immune phagocytosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Reduced Immune Phagocytosis of Monocytes from Neonates Whose Mothers Produce HLA Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

IgG subclasses and Gm allotypes of anti-D antibodies during pregnancy: correlation with the gravity of the fetal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rhesus Du incompatibility in a newborn without hemolytic disease: a possible role for the mononuclear phagocyte system in the benign clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The hydrolysis of rabbit y-globulin and antibodies with crystalline papain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Production of additional atypical alloantibodies in Rh(D)-sensitized pregnancies managed by intrauterine investigation methods

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Intravenous gammaglobulin to prevent stillbirth in rhesus incompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The use of purified 125-I-labelled anti-gamma globulin in the determination of the number of D antigen sites on red cells of different phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

How the management of erythroblastosis fetalis has changed

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Gamma G subgroups in human fetal, cord, and maternal sera

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Failure of passively administered anti-Rh to prevent secondary Rh responses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Experimental studies on Rh immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Immunoglobulin G subclasses and isoimmunized pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Clearance of Rh D-positive red cells with monoclonal anti-D

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Observations on subdivisions of the Rh antigen D

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

ABC of transfusion. Haemolytic disease of the newborn and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

ADCC (K-cell)lysis of human erythrocytes sensitized with rhesus alloantibodies. I. Investigation of in vitro culture variables

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Rh(D) haemolytic disease of the newborn: the changing scene

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Prediction of the severity of rhesus haemolytic disease of the newborn by an ADCC assay

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Prediction of the outcome of rhesus haemolytic disease of the newborn: additional information using an ADCC assay

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Biology of Human Immunoglobulin G Fc Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Transplacental Haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980153-2

7 January 2021

10.1016/S0950-3536(05)80153-2

Identifiers

DOI

1 reference

22 September 2017

1 reference